Sudhakar Selvaraj, MD, PhD, was included in an article on Knowridge Science Report about a clinical trial being conducted at UTHealth to study the effects of psilocybin for treatment-resistant depression. Medical Xpress and News Medical Life Sciences also ran stories about the clinical trial.